GR3015762T3 - Novel physiologically active peptide originating in hog. - Google Patents

Novel physiologically active peptide originating in hog.

Info

Publication number
GR3015762T3
GR3015762T3 GR940403144T GR940403144T GR3015762T3 GR 3015762 T3 GR3015762 T3 GR 3015762T3 GR 940403144 T GR940403144 T GR 940403144T GR 940403144 T GR940403144 T GR 940403144T GR 3015762 T3 GR3015762 T3 GR 3015762T3
Authority
GR
Greece
Prior art keywords
hog
physiologically active
active peptide
edema
novel physiologically
Prior art date
Application number
GR940403144T
Other languages
English (en)
Inventor
Hisayuki Matsuo
Original Assignee
Hisayuki Matsuo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisayuki Matsuo filed Critical Hisayuki Matsuo
Publication of GR3015762T3 publication Critical patent/GR3015762T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR940403144T 1990-04-20 1995-04-13 Novel physiologically active peptide originating in hog. GR3015762T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10504790 1990-04-20
PCT/JP1991/000527 WO1991016342A1 (en) 1990-04-20 1991-04-20 Novel physiologically active peptide originating in hog

Publications (1)

Publication Number Publication Date
GR3015762T3 true GR3015762T3 (en) 1995-07-31

Family

ID=14397086

Family Applications (1)

Application Number Title Priority Date Filing Date
GR940403144T GR3015762T3 (en) 1990-04-20 1995-04-13 Novel physiologically active peptide originating in hog.

Country Status (9)

Country Link
US (1) US5352770A (el)
EP (1) EP0478797B1 (el)
JP (1) JP2636500B2 (el)
AT (1) ATE121102T1 (el)
DE (1) DE69108830T2 (el)
DK (1) DK0478797T3 (el)
ES (1) ES2073751T3 (el)
GR (1) GR3015762T3 (el)
WO (1) WO1991016342A1 (el)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2809533B2 (ja) * 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
BRPI0203172B8 (pt) 2001-09-28 2021-05-25 Nakao Kazuwa composição farmacêutica para acondroplasia
US20080214437A1 (en) * 2002-09-06 2008-09-04 Mohapatra Shyam S Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
US7488713B2 (en) * 2004-03-18 2009-02-10 University Of South Florida Cancer treatment using C-type natriuretic peptides
US8759317B2 (en) 2004-03-18 2014-06-24 University Of South Florida Method of treatment of cancer using guanosine 3′, 5′ cyclic monophosphate (cyclic GMP)
CN1960758B (zh) 2004-03-31 2014-10-22 中外制药株式会社 关节炎的治疗剂或预防剂
EP1743653A4 (en) 2004-03-31 2009-09-30 Kazuwa Nakao COMPOSITION FOR INCREASING BODY SIZE
EP1759001B1 (en) 2004-04-21 2011-04-13 Enobia Pharma Inc. Bone delivery conjugates and method of using same to target proteins to bone
WO2007130672A2 (en) * 2006-05-05 2007-11-15 University Of South Florida Urodilatin cancer treatment
JP2011504506A (ja) * 2007-11-21 2011-02-10 バイオマリン ファーマシューティカル インコーポレイテッド Ｃ型ナトリウム利尿ペプチドの変異体
KR102225470B1 (ko) 2009-05-20 2021-03-10 바이오마린 파머수티컬 인크. 씨형 나트륨이뇨 펩티드의 변이체
CA2823066A1 (en) 2010-12-27 2012-07-05 Alexion Pharma International Sarl Compositions comprising natriuretic peptides and methods of use thereof
US10184942B2 (en) 2011-03-17 2019-01-22 University Of South Florida Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
CA2852874A1 (en) 2011-10-19 2013-04-25 Alexion Pharma Holding Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
ITRM20120060A1 (it) * 2012-02-21 2013-08-22 Consiglio Nazionale Ricerche Peptidi in grado di dissociare lo eterodimero mdm2/mdm4 e loro uso nel trattamento del cancro.
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
MX2017007392A (es) 2014-12-05 2019-01-24 Alexion Pharma Inc Tratamiento de convulsiones con fosfatasa alcalina recombinante.
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
WO2017020034A1 (en) 2015-07-30 2017-02-02 Biomarin Pharmaceutical Inc. Use of c-type natriuretic peptide variants to treat skeletal dysplasia
AU2016308624B2 (en) 2015-08-17 2022-06-23 Alexion Pharmaceuticals, Inc. Manufacturing of alkaline phosphatases
JP6868617B2 (ja) 2015-09-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
EP3368062A4 (en) 2015-10-30 2019-07-03 Alexion Pharmaceuticals, Inc. METHODS OF TREATING CRANIOSYNOSTOSIS IN A PATIENT
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
EP3436020A4 (en) 2016-04-01 2019-12-25 Alexion Pharmaceuticals, Inc. METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS
EP3436052A4 (en) 2016-04-01 2019-10-09 Alexion Pharmaceuticals, Inc. TREATMENT OF MUSCLE WEAKNESS USING ALKALINE PHOSPHATASES
US10988744B2 (en) 2016-06-06 2021-04-27 Alexion Pharmaceuticals, Inc. Method of producing alkaline phosphatase
US11116821B2 (en) 2016-08-18 2021-09-14 Alexion Pharmaceuticals, Inc. Methods for treating tracheobronchomalacia
EP3600383A4 (en) 2017-03-31 2020-10-28 Alexion Pharmaceuticals, Inc. METHODS FOR TREATMENT OF HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS
EP3773684A1 (en) 2018-03-30 2021-02-17 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
PE20220488A1 (es) 2019-09-16 2022-04-04 Biomarin Pharm Inc Variantes del cnp y sus conjugados
EP4291224A1 (en) 2021-02-12 2023-12-20 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof
WO2023283657A1 (en) 2021-07-09 2023-01-12 Biomarin Pharmaceutical Inc. C-type natriuretic peptide variants to treat skeletal dysplasia in children
IL313441A (en) 2021-12-07 2024-08-01 Biomarin Pharm Inc CNP therapy
TW202419463A (zh) 2022-11-02 2024-05-16 丹麥商諾佛 儂迪克股份有限公司 Cnp化合物

Also Published As

Publication number Publication date
ES2073751T3 (es) 1995-08-16
JP2636500B2 (ja) 1997-07-30
ATE121102T1 (de) 1995-04-15
EP0478797A4 (en) 1993-09-01
DE69108830T2 (de) 1995-09-14
DK0478797T3 (da) 1995-06-26
US5352770A (en) 1994-10-04
EP0478797B1 (en) 1995-04-12
WO1991016342A1 (en) 1991-10-31
DE69108830D1 (de) 1995-05-18
EP0478797A1 (en) 1992-04-08

Similar Documents

Publication Publication Date Title
GR3015762T3 (en) Novel physiologically active peptide originating in hog.
RU94018226A (ru) Метансульфонат (е)-3-/2-н-бутил-1-//4-карбоксифенил/метил/-1н-имидазол-5-ил/-2-/2-тиенил/метил-2-пропеновой кислоты, способ его получения, фармацевтическая композиция на его основе
DE3474929D1 (en) Method of encapsulating a substrat
YU86390A (en) Salts fo elastine with increased solubility
HK1000600A1 (en) Xanthine compounds
KR920702371A (ko) 기본 섬유아세포 성장 인자의 효소적 제조방법
ZA845833B (en) Anti-viral compositions
EP0271909A3 (en) Triglyceride composition
ZA852591B (en) Pyridine derivatives and production thereof
RU94006276A (ru) Сложноэфирные соединения, способ их получения и средство для препарации волокна
EP0180994A3 (en) Antihypertensive dialkyl aminoethylaniline derivatives
LU87746A1 (en) A method, bath and cell for the electrodeposition of tin-bismuth alloys
DE3586793D1 (de) Verwendung von vollsynthetischem alpha-hanap.
ES8603604A1 (es) Un metodo para preparar una composicion suavizadora de telas, concentrada, acuosa y estable
AU2302484A (en) Indole derivatives
CN209677991U (zh) 一种新型改良瓷盘底座支撑脚结构
EP0341734A3 (en) Proteins having anti-tumor activity
PL352998A1 (en) Indoloazepines as vasopressin receptor antagonists
EP0374633A3 (de) Verfahren zur Herstellung von Estern der Carboxyalkylpolysaccharide
EP0266006A3 (en) Novel hypotensive diuretic peptides
UA25289C2 (uk) Спосіб приготування горілки "імператорська"
SU1568581A1 (ru) Электролит для осаждения сплава медь - индий